-
Jul 02, 2025
-
Jul 01, 2025
-
Jul 01, 2025
-
Jul 01, 2025
-
Jul 01, 2025
-
Jul 01, 2025
-
Jun 30, 2025
-
Jun 29, 2025
-
Jun 28, 2025
-
Jun 28, 2025
-
Jun 28, 2025
-
Jun 27, 2025Neurocrine Biosciences Presents New Post-Hoc Data Analyses from KINECT®-HD Study Demonstrating Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntington's Disease ChoreaJun 27, 2025, 08:30 ET Share this article SAN DIEGO, June 27, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq:view more
